Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH, USA.
Université Paris Est Créteil, INSERM, IMRB, Créteil, France.
J Feline Med Surg. 2024 Jul;26(7):1098612X241249837. doi: 10.1177/1098612X241249837.
This case series describes seven cats that were treated with high-flow nasal cannula oxygen therapy (HFNOT). Seven cats were prospectively (n = 5) or retrospectively (n = 2) included from three veterinary university referral centers between March 2020 and September 2023. Data on signalment, medical history, clinical and diagnostic findings, treatment administered, response to HFNOT and outcomes were recorded. All cats included in this case series failed to respond to oxygen cage or flow-by oxygen therapy and were subsequently transitioned to HFNOT. After this transition, these cats demonstrated a marked improvement in respiratory parameters, including respiratory rate, effort and oxygen saturation measured by pulse oximetry, within 1 h of initiating HFNOT. All cats tolerated HFNOT well without any complications.
There is limited literature reporting the use of HFNOT in feline patients. This is the first case series in the literature of HFNOT utilized as an advanced oxygen delivery method for feline respiratory failure. This case series indicates that HFNOT improves oxygenation in feline patients that fail to respond to conventional oxygen therapy.
本病例系列描述了 7 只接受高流量鼻导管氧疗（HFNOT）治疗的猫。2020 年 3 月至 2023 年 9 月，3 家兽医大学转诊中心前瞻性（n=5）或回顾性（n=2）纳入了 7 只猫。记录了一般信息、病史、临床和诊断发现、治疗方法、对 HFNOT 的反应和结果。本病例系列中纳入的所有猫均对氧笼或氧气吹入治疗无反应，随后转用 HFNOT。转用 HFNOT 后，这些猫的呼吸参数，包括呼吸频率、呼吸努力和脉搏血氧饱和度，在开始 HFNOT 后 1 小时内显著改善。所有猫均耐受 HFNOT，无任何并发症。
关于 HFNOT 在猫患者中的应用，文献报道有限。这是文献中首例 HFNOT 作为猫呼吸衰竭的高级氧输送方法的病例系列。本病例系列表明，HFNOT 可改善对常规氧疗无反应的猫患者的氧合。
